Client: Janssen Estonia
Period: 2019-2020
The aim of the study was to estimate the prevalence of treatment resistant depression among patients diagnosed with depression in Estonia, estimate the incidence of suicides among depression patients, and to analyse costs associated with treatment resistant depression. The analysis was based on registry data on Estonian residents with health insurance first diagnosed with depression between 2009 and 2019.